会員登録をして、ポイントを貯めよう!

About Sato Top

Global Business

Cultivating and Popularizing
SATO Brands through Six Global Branches

Focusing on the fast-growing ASEAN region, North America, and Europe,
Sato continues to develop its international business through its six branches in Taiwan, Hong Kong, Singapore, China, the US and Germany. We conduct marketing and sales activities carefully tailored to each business location, responding to regional and local needs.

International base and
international business partners

  • International base
  • Technology/product introduction
  • Technology/product export
International base and international business partners International base and international business partners
  • Pfizer Inc. (US)
  • The Procter & Gamble Company (US)
  • Foundation Consumer Brands (US)
  • Novan Inc. (US)
  • AstraZeneca plc (UK)
  • Glaxo Smith Kline (UK)
  • Sanofi (France)
  • IPSEN Consumer HealthCare SAS (France)
  • Laboratoires Dermatologiques D’Uriage (France)
  • Bayer AG (Germany)
  • MEDA Pharma GmbH & Co. KG (Germany)
  • Smart Practise Denmark ApS (Denmark)
  • LEO Pharma A/S (Denmark)
  • CVS Pharmacy (US)
  • Walgreens (US)
  • London Drugs (Canada)
  • Church & Dwight (Australia) Pty Ltd. (Australia)
  • Eisai (Thailand) Marketing Co., Ltd. (Thailand)
  • DKSH (Malaysia)
  • Anugerah Pharmindo Lestari (Indonesia)
  • Baheal Pharmaceutical Group (China)
  • Zuellig Pharma (Vietnam, Philippines, Cambodia)

Marketing

Physical Advertising
Tailored to Regional Characteristics

In physical advertising, we have developed corporate ads at Yankee Stadium in the North America region, bus wrapping advertisements for the SATO brand in Singapore, and other ads tailored to each region.

Digital Advertising
That Communicates the Experiential Value of Products

We are currently enhancing our use of digital advertising, primarily in the ASEAN region. Digital advertising is centered on social networking ads that utilize popular bloggers and others to convey the value of the product experience.

Promoting the Global Expansion of Ethical Drugs

Sato Pharmaceutical is promoting the global expansion
of ethical drugs. Currently, we have obtained for approval for LUCONAC, our topical onychomycosis treatment, in Singapore, and plan to further expand the product in the US and ASEAN.

Back to Business Overview